tiprankstipranks
Standard BioTools (LAB)
NASDAQ:LAB
US Market

Standard BioTools (LAB) Income Statement

Compare
449 Followers

Standard BioTools Income Statement

Last quarter (Q4 2024), Standard BioTools's total revenue was $46.72M, an increase of 65.74% from the same quarter last year. In Q4, Standard BioTools's net income was $-34.07M. See Standard BioTools’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 174.43M$ 106.34M$ 97.95M$ 130.58M$ 138.14M
Gross Profit
$ 84.26M$ 50.45M$ 37.05M$ 69.37M$ 83.33M
Operating Expenses
$ 259.50M$ 127.05M$ 153.26M$ 136.83M$ 134.36M
Depreciation and Amortization
$ 16.86M$ 15.18M$ 15.03M$ 16.07M$ 17.94M
EBITDA
$ -118.14M$ -54.46M$ -173.57M$ -43.77M$ -34.60M
Operating Income
$ -175.24M$ -76.60M$ -116.20M$ -67.46M$ -51.04M
Other Income/Expenses
$ 36.92M$ 2.40M$ -76.72M$ 3.80M$ -3.06M
Pretax Income
$ -138.31M$ -74.20M$ -192.93M$ -63.66M$ -54.10M
Net Income
$ -138.88M$ -74.66M$ -190.10M$ -59.24M$ -53.02M
Per Share Metrics
Basic EPS
$ -0.52$ -0.94$ -2.43$ -0.78$ -0.74
Diluted EPS
$ -0.52$ -0.94$ -2.43$ -0.78$ -0.74
Weighted Average Shares Outstanding
353.25M 79.16M 78.31M 75.79M 72.04M
Weighted Average Shares Outstanding (Diluted)
353.25M 79.16M 78.31M 75.79M 72.04M
Currency in USD

Standard BioTools Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis